2016
DOI: 10.1016/j.autrev.2015.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Role of extracellular vesicles in autoimmune diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
96
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 121 publications
(97 citation statements)
references
References 129 publications
1
96
0
Order By: Relevance
“…Circulating EVs are thought to be released by platelets, erythrocytes and endothelial cells 6, 7 , but EVs from neurons, adipocytes and several other cell types can also be detected 810 . Given that a variety of cell types secrete EVs into the circulation, EVs have recently been identified as attractive biomarkers of tissue-specific diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Circulating EVs are thought to be released by platelets, erythrocytes and endothelial cells 6, 7 , but EVs from neurons, adipocytes and several other cell types can also be detected 810 . Given that a variety of cell types secrete EVs into the circulation, EVs have recently been identified as attractive biomarkers of tissue-specific diseases.…”
Section: Introductionmentioning
confidence: 99%
“…For example, EVs are a source of self antigens, including MHC-displayed self-peptides, that could activate autoreactive T cells (9,67). In addition, the participation of EVs in immune complexes could stimulate autoimmunity.…”
Section: The Role Of Evs In Autoimmunitymentioning
confidence: 99%
“…Depending upon the context and vesicle type, EVs can stimulate or suppress the immune responses to infections with viruses and microbial pathogens as well as cancer. They also likely play a role in modulating inflammatory and autoimmune diseases, such as arthritis, diabetes, and lupus (9). Given their ability to modulate immune responses, EVs have tremendous potential as therapeutic agents for treating a variety of human diseases and disorders, including reducing inflammation, treating autoimmune diseases and cancer, and stimulating antipathogen immune responses.…”
Section: Introductionmentioning
confidence: 99%
“…The differentiation of memory B cells into plasmablasts/plasma cells results in abortive lytic replication of EBV and expression of the dUTPase, which may be released from infected cells through pyroptosis and/or in exosomes. Moreover, exosomes have been implicated in the pathogenesis of RA and SLE [119]. EBV-dUTPase stimulation of human dendritic cells and macrophages in the microenvironment would result in the increased expression and secretion of T H 1/T H 17 proinflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) as well as the anti-inflammatory cytokine IL-10 [7,25,27,29].…”
Section: Herpesviruses Dutpases and Human Diseasementioning
confidence: 99%